Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Venturini

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|November 8, 2003
P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cellsIgor Oruetxebarria, Francesca Venturini, Tuija Kekarainen, et al.
Microorganisms|April 28, 2023
Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 PandemicMaria Mazzitelli, Dario Gregori, Lolita Sasset, et al.
Viruses|February 28, 2023
Molnupiravir and Nirmatrelvir/Ritonavir: Tolerability, Safety, and Adherence in a Retrospective Cohort StudyMaria Mazzitelli, Daniele Mengato, Lolita Sasset, et al.
Clinical and Experimental Medicine|June 8, 2023
Correction to: Changing patterns and clinical outcomes of hospitalized patients with COVID‑19 severe pneumonia treated with remdesivir according to vaccination status: results from a real‑world retrospective studyDaniele Mengato, Maria Mazzitelli, Andrea Francavilla, et al.
Frontiers in Pharmacology|August 22, 2025
Durability and effectiveness of dual vs. triple therapy and tablet simplification in ART: findings from the Italian MOSAICO studyDaniele Mengato, Giacomo Berti, Andrea Francavilla, et al.
Viruses|January 21, 2023
Early Treatments of Fragile Children with COVID-19-Results of CLEVER (Children COVID Early Treatment), a Retrospective, Observational StudyChiara Minotti, Daniele Mengato, Marica De Pieri, et al.
Clinical and Experimental Medicine|March 24, 2023
Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective studyDaniele Mengato, Maria Mazzitelli, Andrea Francavilla, et al.
Frontiers in Pharmacology|November 10, 2025
Implementation and impact analysis of a clinical pharmacy ambulatory: a two-year experienceDaniele Mengato, Laura Camuffo, Federica Todino, et al.
Italian Journal of Pediatrics|November 7, 2024
The role and perception of the caregiver in a specialized pediatric palliative care center in medicine preparation and administration: a survey studyFernando Baratiri, Chiara Zanella, Barbara Roverato, et al.
Journal of Clinical Medicine|October 28, 2023
RAndomized Clinical Trial Of NAfamostat Mesylate, A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 PneumoniaTeresa Maria Seccia, Tungalagtamir Shagjaa, Margherita Morpurgo, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|November 8, 2003
P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cellsIgor Oruetxebarria, Francesca Venturini, Tuija Kekarainen, et al.
Microorganisms|April 28, 2023
Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 PandemicMaria Mazzitelli, Dario Gregori, Lolita Sasset, et al.
Viruses|February 28, 2023
Molnupiravir and Nirmatrelvir/Ritonavir: Tolerability, Safety, and Adherence in a Retrospective Cohort StudyMaria Mazzitelli, Daniele Mengato, Lolita Sasset, et al.
Clinical and Experimental Medicine|June 8, 2023
Correction to: Changing patterns and clinical outcomes of hospitalized patients with COVID‑19 severe pneumonia treated with remdesivir according to vaccination status: results from a real‑world retrospective studyDaniele Mengato, Maria Mazzitelli, Andrea Francavilla, et al.
Frontiers in Pharmacology|August 22, 2025
Durability and effectiveness of dual vs. triple therapy and tablet simplification in ART: findings from the Italian MOSAICO studyDaniele Mengato, Giacomo Berti, Andrea Francavilla, et al.
Viruses|January 21, 2023
Early Treatments of Fragile Children with COVID-19-Results of CLEVER (Children COVID Early Treatment), a Retrospective, Observational StudyChiara Minotti, Daniele Mengato, Marica De Pieri, et al.
Clinical and Experimental Medicine|March 24, 2023
Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective studyDaniele Mengato, Maria Mazzitelli, Andrea Francavilla, et al.
Frontiers in Pharmacology|November 10, 2025
Implementation and impact analysis of a clinical pharmacy ambulatory: a two-year experienceDaniele Mengato, Laura Camuffo, Federica Todino, et al.
Italian Journal of Pediatrics|November 7, 2024
The role and perception of the caregiver in a specialized pediatric palliative care center in medicine preparation and administration: a survey studyFernando Baratiri, Chiara Zanella, Barbara Roverato, et al.
Journal of Clinical Medicine|October 28, 2023
RAndomized Clinical Trial Of NAfamostat Mesylate, A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 PneumoniaTeresa Maria Seccia, Tungalagtamir Shagjaa, Margherita Morpurgo, et al.
Pageof 6